Viewing Study NCT01531894


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-03-06 @ 6:24 PM
Study NCT ID: NCT01531894
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2012-02-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Continuation Study of the Oral AKT Inhibitor GSK2110183
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None solid tumor View
None GSK2110183 View
None hematologic malignancy View
None AKT inhibitor View
None cancer View
None safety View